Retroperitoneal sarcoma in a series of 51 adults.
Standard
Retroperitoneal sarcoma in a series of 51 adults. / Zornig, C; Weh, H J; Krüll, Andreas; Schwarz, R; Dieckmann, J; Rehpenning, W; Schröder, S.
in: EJSO-EUR J SURG ONC, Jahrgang 18, Nr. 5, 5, 1992, S. 475-480.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Retroperitoneal sarcoma in a series of 51 adults.
AU - Zornig, C
AU - Weh, H J
AU - Krüll, Andreas
AU - Schwarz, R
AU - Dieckmann, J
AU - Rehpenning, W
AU - Schröder, S
PY - 1992
Y1 - 1992
N2 - Fifty-one patients with retroperitoneal sarcoma underwent surgery at the University Clinics of Hamburg from 1970 to 1988. Malignant schwannoma, liposarcoma and malignant fibrous histiocytoma were the most common histological types. High grade sarcomas (G3) predominated (42%), while 26% were graded G2 and 33% G1. Complete resection was possible in 59% of cases. Reoperation for local recurrence and debulking in case of not completely resectable disease was common. Regional lymph node metastasis was found in 20% of cases. The peritoneum was the preferred location of metastatic spread. All adjuvant chemotherapies were followed by tumour recurrences. After adjuvant radiotherapy three of six patients remained free of disease. In cases of residual tumour we observed few partial responses on chemo- and radiotherapy, and all patients died because of the disease. The mean survival time was 60 months, the 5- and 10-year survival rates were 35% and 15%, respectively. Factors influencing prognosis in univariate analysis included grade, size, resectability, presence of metastatic spread, histological type, microscopic local growth (infiltrative vs intact pseudocapsule of fibrous tissue) and local recurrence. With multivariate analysis grade, size and lymph node metastasis retained their prognostic significance.
AB - Fifty-one patients with retroperitoneal sarcoma underwent surgery at the University Clinics of Hamburg from 1970 to 1988. Malignant schwannoma, liposarcoma and malignant fibrous histiocytoma were the most common histological types. High grade sarcomas (G3) predominated (42%), while 26% were graded G2 and 33% G1. Complete resection was possible in 59% of cases. Reoperation for local recurrence and debulking in case of not completely resectable disease was common. Regional lymph node metastasis was found in 20% of cases. The peritoneum was the preferred location of metastatic spread. All adjuvant chemotherapies were followed by tumour recurrences. After adjuvant radiotherapy three of six patients remained free of disease. In cases of residual tumour we observed few partial responses on chemo- and radiotherapy, and all patients died because of the disease. The mean survival time was 60 months, the 5- and 10-year survival rates were 35% and 15%, respectively. Factors influencing prognosis in univariate analysis included grade, size, resectability, presence of metastatic spread, histological type, microscopic local growth (infiltrative vs intact pseudocapsule of fibrous tissue) and local recurrence. With multivariate analysis grade, size and lymph node metastasis retained their prognostic significance.
KW - Adult
KW - Humans
KW - Male
KW - Aged
KW - Female
KW - Middle Aged
KW - Adolescent
KW - Multivariate Analysis
KW - Regression Analysis
KW - Lymphatic Metastasis
KW - Prognosis
KW - Survival Rate
KW - Follow-Up Studies
KW - Combined Modality Therapy
KW - Neoplasm Metastasis
KW - Neoplasm Invasiveness
KW - Retroperitoneal Neoplasms/mortality/pathology/surgery
KW - Sarcoma/mortality/pathology/surgery
KW - Adult
KW - Humans
KW - Male
KW - Aged
KW - Female
KW - Middle Aged
KW - Adolescent
KW - Multivariate Analysis
KW - Regression Analysis
KW - Lymphatic Metastasis
KW - Prognosis
KW - Survival Rate
KW - Follow-Up Studies
KW - Combined Modality Therapy
KW - Neoplasm Metastasis
KW - Neoplasm Invasiveness
KW - Retroperitoneal Neoplasms/mortality/pathology/surgery
KW - Sarcoma/mortality/pathology/surgery
M3 - SCORING: Journal article
VL - 18
SP - 475
EP - 480
JO - EJSO-EUR J SURG ONC
JF - EJSO-EUR J SURG ONC
SN - 0748-7983
IS - 5
M1 - 5
ER -